4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001178913-14-002978
Director disposed of 8,556,371 shares (other)
- Director acquired 1,838,109 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bronfeld Zeev Director | 2014-09-16 | Other disposition | −8,556,371 | 1,509,948 | I | ||
| Bronfeld Zeev Director | 2014-09-16 | Other acquisition | +1,838,109 | 1,838,109 | D |
Loading xslF345X03/zk1415563.xml…